- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07367763
The Relationship Between Self-Awareness and Risk of Falls During Walking in Adults (SAFR)
The Relationship Between Self-Awareness and Risk of Falls During Walking in Adults From Rehabilitation Settings and the Community
This study examines the relationship between self-awareness and the risk of falls during walking in older adults and rehabilitation patients. Falls are a major health concern among older adults worldwide. Many studies have shown that executive functions, such as attention and problem-solving, are related to fall risk; however, little is known about the role of self-awareness-the ability to recognize one's own strengths, limitations, and errors-in predicting falls.
In this study, approximately 100 participants (adults aged 60-85 years) will be recruited from both a rehabilitation day center and community settings. Participants will complete cognitive tests, self-awareness questionnaires, and walking assessments using wearable sensors. Walking will be tested both at a normal pace and while performing a secondary task (dual-task walking).
The results will help clarify whether reduced self-awareness is an independent risk factor for falls. Findings may improve fall-prevention strategies in both rehabilitation and community settings.
The study protocol has been reviewed and approved by the Faculty Ethics Committee, University of Haifa, and the Helsinki Committee of Clalit Health Services.
Study Overview
Status
Detailed Description
Falls are among the most common health issues in older adults, with 30-40% of individuals aged 65 and older experiencing at least one fall each year. Falls are strongly associated with reduced quality of life, increased healthcare costs, and higher mortality rates. Executive dysfunction has consistently been identified as a major predictor of fall risk. Yet impaired self-awareness-defined as the ability to accurately evaluate one's own abilities, limitations, and errors-has rarely been studied as an independent risk factor.
The present study is designed to examine whether reduced self-awareness contributes uniquely to fall risk in adults. It combines two cohorts under one protocol: (1) patients recruited from a day rehabilitation center, and (2) community-dwelling older adults. All particpants will undergo identical assessments.
Study outcome measures
- Montreal Cognitive Assessment (MoCA) for global cognition (also a screening test for cognitive decline)
- NeuroTrax™ computerized executive function and attention tests
- Phonemic Verbal Fluency (PVF) task
- Patient Competency Rating Scale (PCRS) and task-specific awareness questionnaires
- Gait analysis using APDM Mobility Lab™ sensors under single-task (normal walking) and dual-task (walking + PVF) conditions
This observational, cross-sectional study will recruit approximately 100 participants (from rehabilitation and from the community). Inclusion criteria: age 60-85 years, Hebrew or Arabic speakers, ambulatory independently or with a cane, and living with a spouse or caregiver who can provide informant data. Exclusion criteria: medical diagnoses significantly affecting cognition or ambulation, hospitalization within the last month, and MoCA score below 20.
The findings are expected to expand the understanding of fall risk factors by highlighting the role of self-awareness. Results may inform future interventions and clinical guidelines for fall prevention in both clinical and community populations.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Haifa, Israel
- University of Haifa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults aged 60-85 years
- Men and women
- Ambulatory independently or with a cane
- Hebrew or Arabic speakers, able to read and write
- Living with a spouse or caregiver who can provide informant questionnaire data
Exclusion Criteria:
- Medical diagnosis significantly affecting cognition, emotion, or ambulation
- Hospitalization within the past month
- Montreal Cognitive Assessment (MoCA) score below 20
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Adults
Adults aged 60-85 living in the community, ambulatory independently or with a cane
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Competency Rating Scale (PCRS-2) Discrepancy Score
Time Frame: baseline
|
Self-awareness will be assessed using the Patient Competency Rating Scale (PCRS-2), which includes both self-report and proxy-report forms.
The outcome measure will be the discrepancy score between patient and caregiver ratings, reflecting the participant's level of awareness across cognitive, emotional, social, and functional domains.
|
baseline
|
|
Gait Speed and Variability
Time Frame: baseline
|
Gait performance will be objectively measured using APDM Mobility Lab sensors.
Primary gait parameters include walking speed (m/s) and step-to-step variability (%).
Dual-task cost will be calculated as the relative change in gait parameters between single-task and dual-task walking, serving as indicators of gait stability and fall risk.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Awareness Walking Questionnaire Score
Time Frame: baseline
|
Participants will complete a short questionnaire rating their perceived walking stability and safety under single-task (normal walking) and dual-task (walking while performing a cognitive task) conditions.
The outcome measure will be the mean score across items, reflecting task-specific self-awareness.
|
baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- COM2-0046-22_076-25
- COM2-0046-22 (Other Identifier: Helsinki Committee, Clalit Health Services)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognitive Dysfunction
-
Universidad Autónoma del Estado de HidalgoEnrolling by invitationCognitive Dysfunction ( MMSE < 24 )Mexico
-
Maria PaçoEnrolling by invitationDietary Supplements | Cognitive Dysfunction, Cognitive DisorderPortugal
-
Mu Dong LiangNot yet recruitingPostoperative Cognitive Dysfunction(POCD)
-
Loma Linda UniversityCompleted1. Postoperative Cognitive DysfunctionUnited States
-
Xijing HospitalFirst Affiliated Hospital Xi'an Jiaotong University; Shanghai 10th People's... and other collaboratorsTerminatedPost Operative Cognitive DysfunctionChina
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPost Operative Cognitive DysfunctionUnited States
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingPOCD - Postoperative Cognitive DysfunctionChina
-
HealthPartners InstituteCompletedPost Operative Cognitive DysfunctionUnited States
-
Burcu Ozalp HorsanaliCompletedPost Operative Cognitive Dysfunction
-
ImmunoChem Therapeutics, LLCNational Cancer Institute (NCI); Northwestern MedicineCompletedCognitive Dysfunction, Cognitive DisorderUnited States